APA (7th ed.) Citation

Xiao, P., Xie, Z., Kuang, Y., Liu, S., Zeng, C., Li, P., & Liu, E. (2021). Discovery of a potent FKBP38 agonist that ameliorates HFD-induced hyperlipidemia via mTOR/P70S6K/SREBPs pathway. Elsevier.

Chicago Style (17th ed.) Citation

Xiao, Ping-Ting, Zhi-Shen Xie, Yu-Jia Kuang, Shi-Yu Liu, Chun Zeng, Ping Li, and E-Hu Liu. Discovery of a Potent FKBP38 Agonist That Ameliorates HFD-induced Hyperlipidemia via MTOR/P70S6K/SREBPs Pathway. Elsevier, 2021.

MLA (8th ed.) Citation

Xiao, Ping-Ting, et al. Discovery of a Potent FKBP38 Agonist That Ameliorates HFD-induced Hyperlipidemia via MTOR/P70S6K/SREBPs Pathway. Elsevier, 2021.